Congratulations to Drs. Radhakrishnan, Luetkens, and Atanackovic for their publication in the February issue of Nature Communications on CD229 CAR T cells to eliminate myeloma plasma cells and memory B cells. Their findings indicate that CD220 CAR T cells may be an effective treatment for patients with multiple myeloma.